This announcement is a separate document:
杭州天目山药业股份有限公司关于公司5%以上大股东签署《股份转让协议》之补充协议暨控制权变更的进展公告
Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the progress of more than 5% of the majority shareholders of the company signed a supplementary agreement to the “Share Transfer Agreement” and a change in control
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.